Cargando…

A novel linear and broadly neutralizing peptide in the SARS-CoV-2 S2 protein for universal vaccine development

Detalles Bibliográficos
Autores principales: Li, Tuofan, Kan, Qiuqi, Ge, Jinying, Wan, Zhimin, Yuan, Mengqi, Huang, Yao, Xie, Quan, Yang, Yi, Shao, Hongxia, Li, Xiangdong, Ye, Lilin, Qin, Aijian, Bu, Zhigao, Liu, Pinghuang, Ye, Jianqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513545/
https://www.ncbi.nlm.nih.gov/pubmed/34645942
http://dx.doi.org/10.1038/s41423-021-00778-6
_version_ 1784583228435202048
author Li, Tuofan
Kan, Qiuqi
Ge, Jinying
Wan, Zhimin
Yuan, Mengqi
Huang, Yao
Xie, Quan
Yang, Yi
Shao, Hongxia
Li, Xiangdong
Ye, Lilin
Qin, Aijian
Bu, Zhigao
Liu, Pinghuang
Ye, Jianqiang
author_facet Li, Tuofan
Kan, Qiuqi
Ge, Jinying
Wan, Zhimin
Yuan, Mengqi
Huang, Yao
Xie, Quan
Yang, Yi
Shao, Hongxia
Li, Xiangdong
Ye, Lilin
Qin, Aijian
Bu, Zhigao
Liu, Pinghuang
Ye, Jianqiang
author_sort Li, Tuofan
collection PubMed
description
format Online
Article
Text
id pubmed-8513545
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85135452021-10-13 A novel linear and broadly neutralizing peptide in the SARS-CoV-2 S2 protein for universal vaccine development Li, Tuofan Kan, Qiuqi Ge, Jinying Wan, Zhimin Yuan, Mengqi Huang, Yao Xie, Quan Yang, Yi Shao, Hongxia Li, Xiangdong Ye, Lilin Qin, Aijian Bu, Zhigao Liu, Pinghuang Ye, Jianqiang Cell Mol Immunol Correspondence Nature Publishing Group UK 2021-10-13 2021-11 /pmc/articles/PMC8513545/ /pubmed/34645942 http://dx.doi.org/10.1038/s41423-021-00778-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Li, Tuofan
Kan, Qiuqi
Ge, Jinying
Wan, Zhimin
Yuan, Mengqi
Huang, Yao
Xie, Quan
Yang, Yi
Shao, Hongxia
Li, Xiangdong
Ye, Lilin
Qin, Aijian
Bu, Zhigao
Liu, Pinghuang
Ye, Jianqiang
A novel linear and broadly neutralizing peptide in the SARS-CoV-2 S2 protein for universal vaccine development
title A novel linear and broadly neutralizing peptide in the SARS-CoV-2 S2 protein for universal vaccine development
title_full A novel linear and broadly neutralizing peptide in the SARS-CoV-2 S2 protein for universal vaccine development
title_fullStr A novel linear and broadly neutralizing peptide in the SARS-CoV-2 S2 protein for universal vaccine development
title_full_unstemmed A novel linear and broadly neutralizing peptide in the SARS-CoV-2 S2 protein for universal vaccine development
title_short A novel linear and broadly neutralizing peptide in the SARS-CoV-2 S2 protein for universal vaccine development
title_sort novel linear and broadly neutralizing peptide in the sars-cov-2 s2 protein for universal vaccine development
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513545/
https://www.ncbi.nlm.nih.gov/pubmed/34645942
http://dx.doi.org/10.1038/s41423-021-00778-6
work_keys_str_mv AT lituofan anovellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT kanqiuqi anovellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT gejinying anovellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT wanzhimin anovellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT yuanmengqi anovellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT huangyao anovellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT xiequan anovellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT yangyi anovellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT shaohongxia anovellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT lixiangdong anovellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT yelilin anovellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT qinaijian anovellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT buzhigao anovellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT liupinghuang anovellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT yejianqiang anovellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT lituofan novellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT kanqiuqi novellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT gejinying novellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT wanzhimin novellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT yuanmengqi novellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT huangyao novellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT xiequan novellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT yangyi novellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT shaohongxia novellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT lixiangdong novellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT yelilin novellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT qinaijian novellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT buzhigao novellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT liupinghuang novellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment
AT yejianqiang novellinearandbroadlyneutralizingpeptideinthesarscov2s2proteinforuniversalvaccinedevelopment